Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24063352 | 0.78 | GRIK1 (0.33) | GRIK1GRIK2 | |
| SCHEMBL3644901 | 0.77 | GRIK1 (0.46) | GRIK1GRIK2 | |
| SCHEMBL11396319 | 0.77 | GRIK1 (0.46) | GRIK1GRIK2 | |
| SCHEMBL5598025 | 0.76 | — | — | |
| SCHEMBL14543421 | 0.75 | GRIK1 (0.33) | GRIK1GRIK2 | |
| SCHEMBL677150 | 0.74 | — | — | |
| SCHEMBL17048005 | 0.74 | GRIK1 (0.43) | GRIK1GRIK2 | |
| SCHEMBL17048008 | 0.74 | GRIK1 (0.43) | GRIK1GRIK2 | |
| SCHEMBL13302483 | 0.73 | GRIK1 (0.60) | GRIK1GRIK2 | |
| SCHEMBL591751 | 0.73 | GRIK1 (0.60) | GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020173536-A1 | Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments | CHRISTIAN NOE AND ERNST MUTSCHLER | 2002-11-21 | — | — | US | disclosed |
| US-6307060-B1 | ANTISPASMODIC AGENTS | Noe, Christian | 2001-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020173536-A1 | Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments | CYP2A13, CYP3A43, HCAR2 | GRIK1 947/4885GRIK2 456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.